Home
>
National Drug Code (NDC)
>
Donnatal Extentabs
Donnatal Extentabs - 66213-421-10 - (Phenobarbital, Hyoscyamine Sulfate, Atropine Sulfate, Scopolamine Hydrobromide)
Drug Information of Donnatal Extentabs
| Product NDC: | 66213-421 |
| Proprietary Name: | Donnatal Extentabs |
| Non Proprietary Name: | Phenobarbital, Hyoscyamine Sulfate, Atropine Sulfate, Scopolamine Hydrobromide |
| Active Ingredient(s): | .0582; .3111; 48.6; .0195 mg/1; mg/1; mg/1; mg/1 & nbsp; Phenobarbital, Hyoscyamine Sulfate, Atropine Sulfate, Scopolamine Hydrobromide |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Donnatal Extentabs
| Product NDC: | 66213-421 |
| Labeler Name: | PBM Pharmaceuticals, Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | |
| Marketing Category: | UNAPPROVED DRUG OTHER |
| Start Marketing Date: | 20080507 |
Package Information of Donnatal Extentabs
| Package NDC: | 66213-421-10 |
| Package Description: | 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (66213-421-10) |
NDC Information of Donnatal Extentabs
| NDC Code | 66213-421-10 |
| Proprietary Name | Donnatal Extentabs |
| Package Description | 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (66213-421-10) |
| Product NDC | 66213-421 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Phenobarbital, Hyoscyamine Sulfate, Atropine Sulfate, Scopolamine Hydrobromide |
| Dosage Form Name | TABLET, FILM COATED, EXTENDED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20080507 |
| Marketing Category Name | UNAPPROVED DRUG OTHER |
| Labeler Name | PBM Pharmaceuticals, Inc |
| Substance Name | ATROPINE SULFATE; HYOSCYAMINE SULFATE; PHENOBARBITAL; SCOPOLAMINE HYDROBROMIDE |
| Strength Number | .0582; .3111; 48.6; .0195 |
| Strength Unit | mg/1; mg/1; mg/1; mg/1 |
| Pharmaceutical Classes | Anticholinergic [EPC],Cholinergic Antagonists [MoA],Cholinergic Muscarinic Antagonist [EPC],Cholinergic Muscarinic Antagonists [MoA],Anticholinergic [EPC],Cholinergic Antagonists [MoA] |
